Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 15;13(3):450-456.
doi: 10.1159/000519147. eCollection 2021 Sep-Dec.

Raynaud's Phenomenon after COVID-19 Vaccination: Causative Association, Temporal Connection, or Mere Bystander?

Affiliations
Case Reports

Raynaud's Phenomenon after COVID-19 Vaccination: Causative Association, Temporal Connection, or Mere Bystander?

Nikolaus Urban et al. Case Rep Dermatol. .

Abstract

Herein, we report a case of a new-onset Raynaud's phenomenon (RP), which occurred in an otherwise healthy 31-year-old Caucasian woman, who lacked any known risk factors and associations with possible causes for secondary RP. However, 2 weeks prior to the development of RP, the patient had received her first injection of the COVID-19 vaccine containing ChAdOx1-SARS-COV-2. The patient presented with well-demarcated, white-pale, cold areas involving the middle fingers of both hands and the ring finger of the right hand, which were triggered by exposure to cold environment and accompanied by a sensation of numbness. Infrared thermography revealed notable temperature differences of up to 10.9°C between affected and nonaffected fingers. Coagulation and immunological parameters, including cryoglobulins and pathological autoantibodies, were within the normal range and antibodies to the heparin/platelet factor 4 complex not detectable. It remains unclear if the development of RP in our patient is causally related to antecedent COVID-19 vaccination; however, the temporal connection to the vaccination, the complete absence of RP in her past medical history, and the lack of any risk factors and triggers raise the suspicion of a yet unknown association with the vaccine. Whether a clear association between the development of RP and COVID-19 vaccination exists or whether RP represents a bystander effect needs to be awaited in case observational reports on RP accumulate. Given the steadily rising numbers of people receiving COVID-19 vaccinations, physicians may remain alert to still unrecognized side effects.

Keywords: COVID-19 vaccination; COVID-19 vaccine; Raynaud's phenomenon; Raynaud's syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Raynaud's phenomenon. Well-demarcated, white-pale, cold areas affecting the middle finger of the left hand of a 31-year old, otherwise healthy, woman.
Fig. 2
Fig. 2
A Nailfold capillaroscopy of the middle finger of the left hand showing normal morphology, density, and dimensions of the capillaries. B Thermogram of both hands, revealing temperature differences of up to 10.9°C between the individual fingers with 21.4°C and 21.2°C in the left index and middle finger, respectively, indicating reduced perfusion, and 32.1°C and 30°C in the right middle and ring finger, indicative of reactive hyperemia.

References

    1. Haque A, Hughes M. Raynaud's phenomenon. Clin Med. 2020 Nov;20((6)):580–7. - PMC - PubMed
    1. Wigley FM, Flavahan NA. Raynaud's Phenomenon. N Engl J Med. 2016 Aug 11;375((6)):556–65. - PubMed
    1. Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015 Mar 16;5((3)):e006389. - PMC - PubMed
    1. Aksay A. A Raynaud phenomonic attack induced after an adult diphtheria-tetanus vaccine. Haydarpasa Numune Med J. 2019;59((3)):296–8. Duzgol.
    1. Selvaraj V, Ogunneye O, Lagu T, Ryzewicz S. A rare case of Raynaud's vasculitis secondary to hepatitis B vaccination: the induced auto-immune attack syndrome. Case Rep Int Med. 2014;1((1)):17–20.

Publication types